U.S. Markets close in 4 hrs 48 mins

Abbott Laboratories (ABT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
48.94-0.35 (-0.72%)
As of 11:12AM EDT. Market open.
People also watch
ABBVBMYLLYJNJMRK
  • E
    Enzrpaide
    Enzrpaide
    On watch for clear above 49.87. Technical 83% chance bullish at foxchart.
  • y
    y
    y
    The stock deserves its run. It is well managed, with decent yield, and hasn't done much in the last two years. The last time it was at current high was in 2015.
  • t
    the voice
    the voice
    Cut us a break Paul...... disgruntle IT worker and or staff.
  • P
    Paul
    Paul
    There are those who watch only shareholder value. I have spent considerable time inside Abbott and the decision to outsource accounting, admin and IT functions to Wipro (through Nancy Berce) is a disaster. It has hobbled the ability of the rank and file (fine people) to DO THEIR JOB efficiently and make their numbers. Tickets are not resolved quickly, passed around and around for days if not weeks. Everybody thinks that the IT staffers are just a bunch of know-nothing geeks and that Noida and Pune can manage everything with a phone call or remote. No true. All of Abbott's business IS computer based and deserves respect. So the shareholder value crowd here .... take a look inside the Abbott container. It has been poisoned.
  • D
    Don
    Don

    The art of being wise is the art of knowing what to overlook. http://dataunion.tistory.com/3755

    Abbott Laboratories NYSE $ABT Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 4,338 NYSE Stocks Price Analysis This stock mode of correlation coefficient is 0.8 In other words, the correlation coefficient of the other stocks
    dataunion.tistory.com
  • T
    Texas
    Texas
    Folks, ole Tex is telling you now to sell this stock. There's no question she falls from here. We've been running the numbers and this stock is due for a pullback. You all know Ole Tex has been right almost every time. Don't miss this opportunity. Happy trading
  • P
    Pharmaherooooooo
    Pharmaherooooooo
    (AXSM) Mcap $90 M /Cash $55 M / 5x Phase 3 programs in various indications targeting huge Markets with first results in Q3 2017 =10+ BAGGER ....The next big player in the making here ! GLTA

    Undiscovered and massive undervalued Biotech Stock with lots of Big News on the way.This Stock is brutally undervalued with a Market cap of just $90 million and $55 million in cash .Founder and Ceo is the larget shareholder holding over 7 million shares (30%) more than 50% of O/S is owned by Insider and Institutions which is a great sign .

    This undiscovered stock could be the next 10 bagger gem if just one of their 5 ongoing Phase 3 programs is successful .GL

    Axsome (AXSM)

    Market-Cap: $90 Million
    Cash: $55 Million(cash runway into the first quarter of 2019.)
    Price:$3.90

    Shares Out: 23.5 Million

    Aegis Capital has reiterated a ‘Buy’ rating and price target of $20 on Axsome Therapeutics (NASDAQ: AXSM) after the company reported financial results for the quarter ended March 31, 2017. The analyst noted that although Axsome reported revenue in-line with consensus estimates, the focus remains on upcoming catalysts such as the company’s ongoing clinical trials. Since February 2017, the company’s AXS-05 has received fast track designation from the FDA for the treatment of Alzheimer’s disease (AD) agitation and treatment resistant depression (TRD). Topline data from the TRD treatment study is expected in the first quarter of 2018. Additionally, Axsome is developing AXS-02 in three separate phase 3 clinical programs, including chronic low back pain associated with modic changes and complex regional pain syndrome, with interim data expected in the fourth quarter of 2017, as well as knee osteoarthritis associated with bone marrow lesions, with interim data expected in the third quarter of 2017.
  • C
    Carl
    Carl
    $BDX conversation

    On Friday, there was a new Medical Devices report posted by The Wall Street Transcript. It has seven new long-form interviews with analysts and executives.

    In addition to $BDX, stocks discussed include $BCR, $MDT$, $ABT, $BAX, $EW, $BSX, $CAH, $VAR, $PTHN, $CTLT, $HRC, $STE, $IVC, $GB, $HYH, $TMO, $DHR, $WAT, $PKI, $A, $BTCY, $ISR, $TCMD, $EYES.

    http://bit.ly/2tnCO2r

  • T
    Texas
    Texas
    Short play at 48.20. Rode it up from 42.60 and now she goes the other way. Happy trading.
  • I
    ICDC WEB
    ICDC WEB
    stock is a bit ahead of its self now. Needs a healthy pullback to $45 or so. Has been amazing run of late.
  • T
    Texas
    Texas
    Good evening folks. Ole Tex was right again about ABT. I do hope everyone here benefited as I did. Ole Tex says, you're welcome.
  • Y
    Yahoo Finance Insights
    Yahoo Finance Insights
    ABT reached a new 52 Week High at 47.70
  • Y
    Yahoo Finance Insights
    Yahoo Finance Insights
    ABT reached a new 52 Week High at 47.22
  • T
    Texas
    Texas

    Folks, it could be breakout time for ABT.

    Abbott Laboratories breached its 50 day moving average in a Bullish Manner : ABT-US : May 5, 2017
    http://www.capitalcube.com/blog/index.php/abbott-laboratories-breached-its-50-day-moving-average-in-a-bullish-manner-abt-us-may-5-2017/?yptr=yahoo

    Abbott Laboratories breached its 50 day moving average in a Bullish Manner : ABT-US : May 5, 2017 – CapitalCube
    www.capitalcube.com
  • R
    Raven
    Raven
    Yea. Follow the money.
  • L
    Lawrence E.
    Lawrence E.
    I'm sure that there is a good reason for ABT continuing to close on the deal for Alere=does anyone know what that reason might be?
  • P
    Peter
    Peter
    一直播 ID:247772407
  • M
    Matthew
    Matthew
    what a #$%$ stock, cant even break out on a win. ive been holding since 2013 and now its time to dump this POS
  • D
    Don
    Don
    Žq
  • T
    Texas
    Texas
    The reason has already been stated in this forum. You just don't want to believe it.